CJC-1295 no DAC 5 mg peptide pen
The short-acting GHRH analogue, five milligrams pre-filled. No DAC means hours not days, a timing property this page refuses to let anyone mistake for weakness.
- ISO-certified laboratory
- COA per batch, ≥99% HPLC
- Discreet dispatch within 24 h
- Research use only
Hours, not days, by design
This is the no-DAC version: CJC-1295 without the drug affinity complex, clearing within hours. What that buys is timing, release prompts that can align with natural pulses rather than flattening them, which is precisely why much of the research prefers it. That timing argument is worked through step by step on the compound page.
Five milligrams pre-filled covers the modest per-use quantities this compound sees. Anyone told the DAC version is stronger has been sold a duration difference dressed as potency; both compound pages here say otherwise.
| Compound | CJC-1295 without DAC |
| Content | 5 mg, pre-filled |
| Class | GHRH analogue |
| Duration | Hours, cleared like the native signal |
| Purity | ≥ 99% (HPLC) |
| WADA | On the prohibited list |
| Category | Research use only |
We stock the no-DAC version deliberately; the compound page defends that choice.
Before the CJC-1295 no DAC 5 mg peptide pen reaches the bench
Standard pen rules; the short half-life changes protocols, not storage.
Short-acting in vivo, steady in the fridge
A fast clearance in the body says nothing about how the cartridge keeps on the shelf.
People shopping for a cjc-1295 no dac pen fixate on its defining feature, clearance in hours rather than days, and let that colour their expectations about storage, though the two are unrelated. The no-DAC design shortens how long the GHRH analogue acts inside a system; it does nothing to make the peptide sturdier in the cartridge. So the five-milligram pen keeps the same cold discipline as every other on the shelf, the one the storage page lays out: refrigerated between sessions, never frozen, out of light, first use dated on the barrel.
After first use the in-use clock runs like any pen’s, so the date on the barrel is what tells you where the cartridge stands weeks later. Five milligrams comfortably covers the modest per-use quantities this analogue sees, so a single lot usually carries a protocol from start to finish. The short half-life may push sessions closer together, but that is a scheduling matter for the protocol, it never shortens the time the sealed, refrigerated cartridge itself stays sound.
One GHRH analogue, among its neighbours
Set beside its neighbours, this pen’s particular job gets easier to see.
On the GHRH shelf this pen takes the middle rung. Sermorelin, the bare active fragment, lasts only minutes; tesamorelin, the same design carried to an approval, sits at the far end, its trials listed on ClinicalTrials.gov; the no-DAC CJC-1295 here lands between them, active for hours. Its nearest neighbour is the DAC version, where the honest difference is duration, not power, DAC blankets days, this clears fast. The five-milligram no-DAC pen is the short-acting end of the range, chosen on purpose.
Step off the GHRH shelf and the next neighbour works a different receptor: ipamorelin runs the ghrelin route, not the GHRH one, so it complements this compound rather than competing with it. That is why the two also exist fused in one combination cartridge. The solo five-milligram pen earns its place whenever a protocol wants the GHRH signal alone, to time it against natural pulses, or to vary it independently of any ghrelin input, which the fixed-ratio combination will not allow.
The other half
The ghrelin-route partner, and both compounds in one cartridge.
The science behind CJC-1295 no DAC
Duration, pulsatility and the approved relative.
Questions about the CJC-1295 no DAC 5 mg peptide pen
The no-DAC questions.